![Joe Jimenez, CEO of Swiss drugmaker Novartis gestures during an interview with Reuters at the company's headquarters in Basel March 19, 2014. Novartis Chief Executive Joe Jimenez is taking a hard look Joe Jimenez, CEO of Swiss drugmaker Novartis gestures during an interview with Reuters at the company's headquarters in Basel March 19, 2014. Novartis Chief Executive Joe Jimenez is taking a hard look](https://c8.alamy.com/compfr/2ck40ca/joe-jimenez-pdg-de-la-societe-pharmaceutique-suisse-novartis-s-adresse-a-la-conference-de-presse-annuelle-de-la-societe-a-bale-en-suisse-le-27-janvier-2016-novartis-a-declare-qu-elle-remplacerait-la-direction-de-sa-division-des-soins-oculaires-alcon-apres-que-le-drogurier-suisse-ait-manque-les-previsions-de-revenus-du-quatrieme-trimestre-il-a-egalement-declare-que-les-ventes-et-les-benefices-globaux-de-2016-stagneront-probablement-au-milieu-de-3-milliards-de-dollars-d-expirations-de-brevets-reuters-arnd-wiegmann-2ck40ca.jpg)
Joe Jimenez, CEO of Swiss drugmaker Novartis gestures during an interview with Reuters at the company's headquarters in Basel March 19, 2014. Novartis Chief Executive Joe Jimenez is taking a hard look
![Paul Hastings Adds Elite NY Finance Lawyer Morgan Bale to Powerhouse Global Team | Paul Hastings LLP Paul Hastings Adds Elite NY Finance Lawyer Morgan Bale to Powerhouse Global Team | Paul Hastings LLP](https://images.ctfassets.net/t0ydv1wnf2mi/1b7L9iCp7qQIcJdNVjje0O/56664aedb39629b051d3e01fecd06a03/Morgan_Bale_Paul_Hastings.jpg)
Paul Hastings Adds Elite NY Finance Lawyer Morgan Bale to Powerhouse Global Team | Paul Hastings LLP
![Joe Jimenez, CEO of Swiss drugmaker Novartis gestures during an interview with Reuters at the company's headquarters in Basel March 19, 2014. Novartis Chief Executive Joe Jimenez is taking a hard look Joe Jimenez, CEO of Swiss drugmaker Novartis gestures during an interview with Reuters at the company's headquarters in Basel March 19, 2014. Novartis Chief Executive Joe Jimenez is taking a hard look](https://c8.alamy.com/compfr/2cmk69c/joe-jimenez-pdg-de-la-societe-pharmaceutique-suisse-novartis-s-adresse-a-la-conference-de-presse-annuelle-de-la-societe-a-bale-en-suisse-le-27-janvier-2016-novartis-a-declare-qu-elle-remplacerait-la-direction-de-sa-division-des-soins-oculaires-alcon-apres-que-le-drogurier-suisse-ait-manque-les-previsions-de-revenus-du-quatrieme-trimestre-il-a-egalement-declare-que-les-ventes-et-les-benefices-globaux-de-2016-stagneront-probablement-au-milieu-de-3-milliards-de-dollars-d-expirations-de-brevets-reuters-arnd-wiegmann-2cmk69c.jpg)